^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
SG1906
i
Other names: SG1906, SG 1906, SG-1906
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Sumgen Biotech
Drug class:
CD47 inhibitor, CLDN18.2 inhibitor
Related drugs:
12ms
CSG-1906-101: SG1906 for CLDN18.2-Positive Solid Tumors (clinicaltrials.gov)
P1, N=60, Recruiting, Hangzhou Sumgen Biotech Co., Ltd. | Phase classification: P1a/1b --> P1
Phase classification • Metastases
|
CLDN18 (Claudin 18)
|
CLDN18.2 positive
|
SG1906
over1year
CSG-1906-101: SG1906 for CLDN18.2-Positive Solid Tumors (clinicaltrials.gov)
P1a/1b, N=60, Recruiting, Hangzhou Sumgen Biotech Co., Ltd.
New P1 trial • Metastases
|
CLDN18 (Claudin 18)
|
CLDN18.2 positive
|
SG1906
Share via
